Suzanne Hendrix
Suzanne Hendrix
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
GK Wilcock, SE Black, SB Hendrix, KH Zavitz, EA Swabb, MA Laughlin, ...
The Lancet Neurology 7 (6), 483-493, 2008
Sensory, mechanical, and microscopic evaluation of staling in low‐protein and gluten‐free breads
GJ Ahlborn, OA Pike, SB Hendrix, WM Hess, CS Huber
Cereal chemistry 82 (3), 328-335, 2005
Report of the task force on designing clinical trials in early (predementia) AD
PS Aisen, S Andrieu, C Sampaio, M Carrillo, ZS Khachaturian, B Dubois, ...
Neurology 76 (3), 280-286, 2011
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force
B Vellas, MC Carrillo, C Sampaio, HR Brashear, E Siemers, H Hampel, ...
Alzheimer's & Dementia 9 (4), 438-444, 2013
Safety, tolerability, pharmacokinetics, and Aβ levels after short-term administration of R-flurbiprofen in healthy elderly individuals
DR Galasko, N Graff-Radford, S May, S Hendrix, BA Cottrell, SA Sagi, ...
Alzheimer Disease & Associated Disorders 21 (4), 292-299, 2007
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
JB Langbaum, SB Hendrix, N Ayutyanont, K Chen, AS Fleisher, RC Shah, ...
Alzheimer's & Dementia 10 (6), 666-674, 2014
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
H Soininen, A Solomon, PJ Visser, SB Hendrix, K Blennow, M Kivipelto, ...
The Lancet Neurology 16 (12), 965-975, 2017
The Alzheimer’s prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer’s disease treatments in presenilin 1 …
N Ayutyanont, JB Langbaum, SB Hendrix, K Chen, AS Fleisher, ...
The Journal of clinical psychiatry 75 (6), 652, 2014
Multivariate analysis for the biobehavioral and social sciences: A graphical approach
BL Brown, SB Hendrix, DW Hedges, TB Smith
John Wiley & Sons, 2011
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
J Wang, V Logovinsky, SB Hendrix, SH Stanworth, C Perdomo, L Xu, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (9), 993-999, 2016
Prevention trials in Alzheimer's disease: an EU-US task force report
B Vellas, PS Aisen, C Sampaio, M Carrillo, P Scheltens, B Scherrer, ...
Progress in neurobiology 95 (4), 594-600, 2011
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
B Lawlor, R Segurado, S Kennelly, MGM Olde Rikkert, R Howard, ...
PLoS medicine 15 (9), e1002660, 2018
Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
A Atri, SB Hendrix, V Pejović, RK Hofbauer, J Edwards, JL Molinuevo, ...
Alzheimer's research & therapy 7 (1), 28, 2015
The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to …
PN Tariot, F Lopera, JB Langbaum, RG Thomas, S Hendrix, LS Schneider, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018
Witness and nonwitness children's violent and peaceful behavior in different types of simulated conflict with peers
B Ballif‐Spanvill, CJ Clayton, SB Hendrix
American journal of orthopsychiatry 77 (2), 206-215, 2007
Gender, types of conflict, and individual differences in the use of violent and peaceful strategies among children who have and have not witnessed interparental violence
B Ballif‐Spanvill, CJ Clayton, SB Hendrix
American Journal of Orthopsychiatry 73 (2), 141-153, 2003
O3‐04–01: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18‐month multi‐center phase 3 trial
RC Green, LS Schneider, SB Hendrix, KH Zavitz, E Swabb
Alzheimer's & Dementia 4, T165-T165, 2008
Outcomes assessment in clinical trials of Alzheimer’s disease and its precursors: readying for short-term and long-term clinical trial needs
H Posner, R Curiel, C Edgar, S Hendrix, E Liu, DA Loewenstein, ...
Innovations in clinical neuroscience 14 (1-2), 22, 2017
Statistical comparator interface
B Brown, K Hendrix, S Hendrix
US Patent App. 10/281,894, 2003
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
A Hobden, K Zavitz, G Mather, S Hendrix
US Patent App. 10/889,971, 2005
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20